封面
市場調查報告書
商品編碼
1626555

全球醫療保健 3D 列印市場規模(按產品、技術、應用、地區、範圍和預測)

Global Healthcare 3D Printing Market Size by Product, By Technology (Fused Deposition Modelling, Selective Laser Sintering, Stereolithography), By Application, By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

醫療保健 3D 列印市場規模及預測

2023 年醫療保健 3D 列印市場規模價值 33.8 億美元,預計到 2031 年將達到 122.6 億美元,2024 年至 2031 年的複合年增長率為 19.29%。

醫療保健 3D 列印是使用積層製造技術生產個人化醫療產品和植入物的過程。該技術可在骨科、關節置換和手術規劃方面提供精確的、針對患者的解決方案。

該技術用於創建植入物、人工關節和手術前規劃的解剖模型。個人化的植入物和手術器械可改善患者的治療效果並簡化手術程序。

未來的應用包括組織和器官的生物列印,以及義肢和植入物。它有可能推動再生醫學和個人化治療的進步,徹底改變疾病的治療方式。

全球醫療保健 3D 列印市場動態

主要市場推動因素

技術進步:3D 列印技術的進步將透過提高精度、速度和材料能力來推動成長,擴大個人化植入物、義肢和手術規劃的應用。

個人化醫療需求不斷增長:隨著人們尋求個人化的醫療保健解決方案,對客製化植入物和人工關節的需求不斷增長,這些植入物和人工關節可以適應每個患者的需求,從而推動市場成長。

慢性病發病率上升:慢性病發病率不斷上升,需要個人化的 3D 列印醫療設備等先進的替代治療方法。

主要課題

監管障礙:取得3D列印醫療設備的各種法規和批准非常困難且耗時,阻礙了市場發展和產品開發。

成本高:3D 列印技術和材料的初始成本高,可能會限制其普及和廣泛採用,尤其是在資源受限的醫療保健環境中。

材料限制:醫療保健領域可用於 3D 列印的材料數量仍然有限,從而降低了列印醫療設備和植入物的功能和壽命。

品質和標準化:保持一致的品質並滿足 3D 列印醫療設備的嚴格要求非常困難,從而損害了其在臨床環境中的可靠性和普遍採用。

主要趨勢:

生物列印技術的進步:生物列印技術的進步使得創建複雜的組織和器官原型成為可能,突破了再生醫學的界限。

與數位健康技術的融合:將 3D 列印與影像和 CAD 軟體等數位健康工具相結合,將提高醫療器材製造和手術規劃的準確性。

新興市場的擴張:新興市場醫療保健投資的增加推動了 3D 列印產業的成長,增加了世界獲得最新醫療技術的機會。

目錄

第 1 章全球醫療保健 3D 列印市場介紹

  • 市場介紹
  • 調查範圍
  • 先決條件

第 2 章執行摘要

第3章 VERIFIED MARKET RESEARCH研究方法

  • 數據挖掘
  • 驗證
  • 一次資料
  • 數據源列表

第4章 全球醫療3D列印市場展望

  • 概述
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力模型
  • 價值鏈分析

第 5 章 全球醫療保健 3D 列印市場(按技術劃分)

  • 概述
  • 注射器底座
  • 磁浮
  • 基於雷射
  • 噴墨底座

第6章 全球醫療保健 3D 列印市場(按應用)

  • 概述
  • 熔融沈積成型 (FDM)
  • 選擇性激光燒結 (SLS)
  • 立體光刻

第 7 章 全球醫療保健 3D 列印市場(按最終用戶)

  • 概述
  • 生物傳感器
  • 醫療的
  • 藥品
  • 義肢和植入物
  • 組織和器官生成
  • 牙科

第8章全球醫療保健 3D 列印市場(按地區)

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 世界其他地區
    • 拉丁美洲
    • 中東/非洲

第9章全球醫療保健 3D 列印市場:競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第10章 公司簡介

  • Cyfuse Biomedical
  • Aprecia Pharmaceuticals
  • Aspect Biosystems
  • Bio 3D Technologies
  • BioBots
  • 3Dynamics Systems
  • Envision TEC
  • Luxexel
  • Materialise NV
  • Nano3D Biosciences
  • Oceanz
  • Organovo Holdings, Inc.
  • regenHU
  • Digilab

第12章 附錄

  • 相關研究
簡介目錄
Product Code: 26454

Healthcare 3D Printing Market Size And Forecast

Healthcare 3D Printing Market size was valued at USD 3.38 Billion in 2023 and is projected to reach USD 12.26 Billion by 2031 growing at a CAGR of 19.29% from 2024 to 2031.

Healthcare 3D printing is the process of making personalized medical items and implants using additive manufacturing. This technique allows for precise, patient-specific solutions in orthopedics, prostheses and surgical planning.

It is used to create implants, prostheses and anatomical models for pre-surgical planning. Personalized implants and surgical instruments enhance patient outcomes and simplify surgical procedures.

Future applications include bioprinting tissues and organs, in addition to prostheses and implants. It offers advances in regenerative medicine and individualized treatment, which could transform how medical diseases are handled and treated.

Global Healthcare 3D Printing Market Dynamics

The key market dynamics that are shaping the global healthcare 3D printing market include:

Key Market Drivers:

Technological Advancements: Advancements in 3D printing technology improve precision, speed and material possibilities, boosting growth by expanding its uses in personalized implants, prostheses and surgical planning.

Rising Demand for Personalized Medicine: As people want personalized healthcare solutions, there is a greater demand for custom-made implants and prostheses adapted to individual patient demands, which is driving market growth.

Growing Incidence of Chronic Diseases: Chronic disease prevalence is increasing, necessitating sophisticated treatment alternatives such as personalized 3D-printed medical equipment, which is driving market demand.

Key Challenges:

Regulatory Obstacles: Navigating several regulations and securing clearances for 3D-printed medical equipment can be difficult and time-consuming, hindering market penetration and product development.

High Costs: High initial costs for 3D printing technology and materials might limit accessibility and uptake, particularly in resource-constrained healthcare settings.

Material Limitations: The number of materials available for 3D printing in healthcare remains limited, reducing the functionality and lifetime of printed medical devices and implants.

Quality and Standardization: Maintaining consistent quality and meeting demanding requirements for 3D-printed medical devices is difficult, compromising reliability and universal adoption in clinical settings.

Key Trends:

Advancements in Bioprinting: Bioprinting advances are allowing for the creation of complex tissues and organ prototypes, pushing the boundaries of regenerative medicine.

Integration with Digital Health Technologies: Combining 3D printing with digital health tools like imaging and CAD software improves precision in medical device manufacture and surgery planning.

Expansion in Emerging Markets: Rising healthcare investments in emerging markets are driving the growth of the 3D printing industry, increasing global access to modern medical technology.

Global Healthcare 3D Printing Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare 3D printing market:

North America:

According to Verified Market Research, North America is expected to dominate the global healthcare 3D printing market.

North America is predicted to dominate the worldwide healthcare 3D printing market due to its strong technological infrastructure, considerable R&D investments and high healthcare spending.

The region's strong emphasis on innovation and individualized medicine, combined with a solid healthcare system and early embrace of cutting-edge technologies, puts it as a pioneer in the development and implementation of 3D printing solutions in healthcare.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global healthcare 3D printing market.

Asia-Pacific is the fastest-growing region in the worldwide healthcare 3D printing market, owing to rapid advances in medical technology, increasing healthcare investments and rising demand for individualized medical solutions.

The region benefits from expanded healthcare infrastructure and government efforts that promote innovation. increasing usage of 3D printing in medical applications, such as prosthetics and implants, fuels growth, establishing Asia-Pacific as a prominent player in market expansion.

Global Healthcare 3D Printing Market: Segmentation Analysis

The Global Healthcare 3D Printing Market is segmented based on Product, Technology, Application and Geography.

Healthcare 3D Printing Market, By Technology

  • Syringe Based
  • Magnetic Levitation
  • Laser Based
  • Inkjet Based

Based on Technology, the Global Healthcare 3D Printing Market is separated into Syringe Based, Magnetic Levitation, Laser Based, and Inkjet Based. Laser-based technology leads the worldwide healthcare 3D printing market due to its precision, adaptability and capacity to create high-quality, complicated structures for medical implants and equipment.

Healthcare 3D Printing Market, By Application

  • Fused Deposition Modelling (FDM)
  • Selective Laser Sintering (SLS)
  • Stereolithography

Based on Application, Global Healthcare 3D Printing Market is divided into Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), and Stereolithography. Fused Deposition Modeling (FDM) leads the global healthcare 3D printing industry due to its low cost and versatility in producing medical implants, prosthetics and anatomical models.

Healthcare 3D Printing Market, By End-User

  • Biosensors
  • Medical
  • Pharmaceuticals
  • Prosthetics and Implants
  • Tissue and Organ Generation
  • Dental

Based on End-User, Global Healthcare 3D Printing Market is divided into Biosensors, Medical, Pharmaceuticals and Dental. The worldwide healthcare 3D printing market is dominated by prosthetics and implants due to rising demand for individualized medical devices and improvements in materials and technology for tailored patient solutions.

Healthcare 3D Printing Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Healthcare 3D Printing Market divided into North America, Europe, Asia Pacific and Rest of the World. North America leads the global healthcare 3D printing market due to superior technology and high healthcare costs. However, Asia-Pacific is the fastest-growing area, owing to increasing healthcare investments, expanded medical infrastructure and rising demand for individualized medical solutions.

Key Players

  • The Global Healthcare 3D Printing Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cyfuse Biomedical, Aprecia Pharmaceuticals, Aspect Biosystems, Bio 3D Technologies, BioBots, 3Dynamics Systems, Envision TEC, Luxexel, Materialise NV, Nano3D Biosciences, Oceanz, Organovo Holdings, Inc., regenHU, Digilab.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

  • Global Healthcare 3D Printing Market Recent Developments
  • In November 2022, Evonik introduces three new INFINAM photopolymers for industrial 3D applications, expanding their photo-resins product portfolio. The product range is designed for use in standard UV-curing 3D printing techniques. The INFINAM RG 2000 L is a photo resin designed for the eyeglass industry.
  • In June 2022, Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical collaborated to deliver an innovative and quick turnaround procedure for 3D-printed medical equipment. Both Amnovis and BAAT Medical have experience 3D printing medical equipment for a variety of certified end-user applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL HEALTHCARE 3D PRINTING MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL HEALTHCARE 3D PRINTING MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Syringe Based
  • 5.3 Magnetic Levitation
  • 5.4 Laser Based
  • 5.5 Inkjet Based

6 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Fused Deposition Modelling (FDM)
  • 6.3 Selective Laser Sintering (SLS)
  • 6.4 Stereolithography

7 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Biosensors
  • 7.3 Medical
  • 7.4 Pharmaceuticals
  • 7.5 Prosthetics and Implants
  • 7.6 Tissue and Organ Generation
  • 7.7 Dental

8 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL HEALTHCARE 3D PRINTING MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Cyfuse Biomedical
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • Aprecia Pharmaceuticals
  • Aspect Biosystems
  • Bio 3D Technologies
  • BioBots
  • 3Dynamics Systems<
  • Envision TEC
  • Luxexel
  • Materialise NV
  • Nano3D Biosciences
  • Oceanz
  • Organovo Holdings, Inc.
  • regenHU
  • Digilab

12 Appendix

  • 12.1 Related Research